Sign in to view content

GATHER2 Phase 3 Efficacy Results and GATHER2 Phase 3 Safety Results

Jeffrey S. Heier, MD
Arshad M. Khanani, MD, MA, FASRS

Video
Published 2022

Related

Outcomes of DRCR Network Treatment Regimen Starting with Observation for Eyes With Center-involved Diabetic Macular Edema and Good Visual Acuity
Omar S. Punjabi, MD
Updates from the Field
2019
Cell Therapies for Atrophic AMD
Allen C Ho, MD FASRS
Updates from the Field
2020
Staring a Clinical Trials Program
David A. Eichenbaum, MD, FASRS
Updates from the Field
2019

Category: AMD - Non-neovascular

See more